Michael Barbella, Managing Editor03.26.24
Mirai Medical has welcomed former Boston Scientific Corp. executive David A. Pierce to its board as a non-executive director.
“We are thrilled to welcome David to our board. His extensive experience at Boston Scientific, coupled with his deep knowledge of the industry, will undoubtedly play a pivotal role in guiding Mirai Medical's strategic direction,” Mirai Medical CEO Declan Soden, Ph.D., said. “We are confident that Mr. Pierce's contributions will further elevate our capabilities and impact in interventional endoscopy.”
Formerly executive vie president and president of MedSurg, and president of Endoscopy at Boston Scientific, Pierce's career at the medical device firm spanned 31 years. His expertise in product commercialization, market access, and clinical change management in the gastrointestinal endoscopy space positions him as a valuable addition to Mirai Medical's leadership team, according to Mirai Medical.
“I am honoured to be part of Mirai Medical, a company at the forefront of innovation in interventional endoscopy. The mission to enable every endoscopist to treat at diagnosis resonates strongly with me, and I look forward to contributing to the company's growth and success,” Pierce stated.
Mirai Medical is a medtech start-up specializing in pulsed field ablation within the gastrointestinal tract. It aims to empower every endoscopist to treat at diagnosis. The company's proprietary ePORE therapy is designed with precise algorithmic control of PFA parameters enabling the safe and effective treatment of both pre-malignant and malignant disease across the entire gastrointestinal tract. Mirai Medical are headquartered in Galway, Ireland.
“We are thrilled to welcome David to our board. His extensive experience at Boston Scientific, coupled with his deep knowledge of the industry, will undoubtedly play a pivotal role in guiding Mirai Medical's strategic direction,” Mirai Medical CEO Declan Soden, Ph.D., said. “We are confident that Mr. Pierce's contributions will further elevate our capabilities and impact in interventional endoscopy.”
Formerly executive vie president and president of MedSurg, and president of Endoscopy at Boston Scientific, Pierce's career at the medical device firm spanned 31 years. His expertise in product commercialization, market access, and clinical change management in the gastrointestinal endoscopy space positions him as a valuable addition to Mirai Medical's leadership team, according to Mirai Medical.
“I am honoured to be part of Mirai Medical, a company at the forefront of innovation in interventional endoscopy. The mission to enable every endoscopist to treat at diagnosis resonates strongly with me, and I look forward to contributing to the company's growth and success,” Pierce stated.
Mirai Medical is a medtech start-up specializing in pulsed field ablation within the gastrointestinal tract. It aims to empower every endoscopist to treat at diagnosis. The company's proprietary ePORE therapy is designed with precise algorithmic control of PFA parameters enabling the safe and effective treatment of both pre-malignant and malignant disease across the entire gastrointestinal tract. Mirai Medical are headquartered in Galway, Ireland.